Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Shadab Md, Shadabul Haque, Jasjeet Kaur Sahni, Sanjula Baboota & Javed Ali. (2011) New non-oral drug delivery systems for Parkinson's disease treatment. Expert Opinion on Drug Delivery 8:3, pages 359-374.
Read now
Read now
Michael J Aminoff. (2003) Neuroprotective treatment for Parkinson’s disease. Expert Review of Neurotherapeutics 3:6, pages 797-804.
Read now
Read now
Articles from other publishers (18)
N. Poovaiah, Z. Davoudi, H. Peng, B. Schlichtmann, S. Mallapragada, B. Narasimhan & Q. Wang. (2018) Treatment of neurodegenerative disorders through the blood–brain barrier using nanocarriers. Nanoscale 10:36, pages 16962-16983.
Crossref
Crossref
Kai Liu, Huamin Xu, Hengwei Xiang, Peng Sun & Junxia Xie. (2015) Protective effects of Ndfip1 on MPP+-induced apoptosis in MES23.5 cells and its underlying mechanisms. Experimental Neurology 273, pages 215-224.
Crossref
Crossref
ZeGang Ma, Yu Zhou & JunXia Xie. (2012) Nifedipine Prevents Iron Accumulation and Reverses Iron-Overload-Induced Dopamine Neuron Degeneration in the Substantia Nigra of Rats. Neurotoxicity Research 22:4, pages 274-279.
Crossref
Crossref
Rong Wang, Zegang Ma, Jun Wang & Junxia Xie. (2011) L-Type Cav1.2 Calcium Channel is Involved in 6-Hydroxydopamine-Induced Neurotoxicity in Rats. Neurotoxicity Research 21:3, pages 266-270.
Crossref
Crossref
Kai Zhang, ZeGang Ma, Jun Wang, AnMu Xie & JunXia Xie. (2011) Myricetin attenuated MPP+-induced cytotoxicity by anti-oxidation and inhibition of MKK4 and JNK activation in MES23.5 cells. Neuropharmacology 61:1-2, pages 329-335.
Crossref
Crossref
Jun Wang, Hua-Min Xu, Hai-Dong Yang, Xi-Xun Du, Hong Jiang & Jun-Xia Xie. (2009) Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins. Neurochemistry International 54:1, pages 43-48.
Crossref
Crossref
G. Linazasoro. (2008) Potential applications of nanotechnologies to Parkinson's disease therapy. Parkinsonism & Related Disorders 14:5, pages 383-392.
Crossref
Crossref
Yael Avramovich-Tirosh, Tamar Amit, Orit Bar-Am, Hailin Zheng, Mati Fridkin & Moussa B. H. Youdim. (2007) Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator?monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease. Journal of Neurochemistry 100:2, pages 490-502.
Crossref
Crossref
Justyna Ostrowska, Wojciech Łuczaj, Agnieszka Augustyniak & Elżbieta Skrzydlewska. 2007. Oxidative Stress and Neurodegenerative Disorders. Oxidative Stress and Neurodegenerative Disorders
581
605
.
Silvia Mandel, Tamar Amit, Lydia Reznichenko, Orly Weinreb & Moussa B. H. Youdim. (2006) Green tea catechins as brain‐permeable, natural iron chelators‐antioxidants for the treatment of neurodegenerative disorders. Molecular Nutrition & Food Research 50:2, pages 229-234.
Crossref
Crossref
S. Mandel, O. Weinreb, L. Reznichenko, L. Kalfon & T. Amit. 2006. Oxidative Stress and Neuroprotection. Oxidative Stress and Neuroprotection
249
257
.
Silvia Mandel, Tamar Amit, Moussa Youdim & Orly Weinreb. 2005. Molecular Interventions in Lifestyle-Related Diseases. Molecular Interventions in Lifestyle-Related Diseases
155
174
.
Silvia A. Mandel, Yael Avramovich-Tirosh, Lydia Reznichenko, Hailin Zheng, Orly Weinreb, Tamar Amit & Moussa B.H. Youdim. (2005) Multifunctional Activities of Green Tea Catechins in Neuroprotection. Neurosignals 14:1-2, pages 46-60.
Crossref
Crossref
Orly Weinreb, Silvia Mandel, Tamar Amit & Moussa B.H. Youdim. (2004) Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases. The Journal of Nutritional Biochemistry 15:9, pages 506-516.
Crossref
Crossref
Silvia Mandel & Moussa B.H Youdim. (2004) Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radical Biology and Medicine 37:3, pages 304-317.
Crossref
Crossref
Silvia Mandel, Orly Weinreb, Tamar Amit & Moussa B. H. Youdim. (2004) Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases. Journal of Neurochemistry 88:6, pages 1555-1569.
Crossref
Crossref
Silvia Mandel, Orly Weinreb & Moussa B.H Youdim. (2003) Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugs. Trends in Pharmacological Sciences 24:4, pages 184-191.
Crossref
Crossref
Silvia Mandel, Edna Gr??nblatt, Peter Riederer, Manfred Gerlach, Yona Levites & Moussa B H Youdim. (2003) Neuroprotective Strategies in Parkinson???s Disease. CNS Drugs 17:10, pages 729-762.
Crossref
Crossref